Biomedical research is specially known for producing large amounts of data—from genomics to proteomics to metabolomics. Besides the sheer storage that is needed, findings can be scattered in laboratories accross different countries and many times locked behind proprietary software or paywalls. A 2017 article from the Trends in Biotechnology journal, titled “Metabolizing Data in the Cloud” by Warth et al. [1], shows how cloud platforms solve this by delivering global sharing and accessibility without the need of expensive local hardware.
The paper spotlights XCMS Online, a cloud platform with over 50,000 users that handles untargeted metabolomics data end-to-end: from raw LC/MS processing, statistical analysis, metabolite identification via METLIN database, pathway mapping, and multi-omics integration.
- Cost savings: Over $70M saved for the community vs. vendor software (projected $250M by 2021), with development costs under $2M.
- Data sharing: 135K+ file shares enable collaboration and reproducibility across 120+ countries.
- Speed: XCMS Stream cuts analysis time from days to minutes.
Challenges like data security and internet dependency remain, but enterprise-grade protections and standardization address them. The article positions metabolomics as a leader in cloud implementation, paving the way for systems biology integration. Nearly a decade later, XCMS Online’s model inspired platforms like PhenoMeNal and METASPACE, proving cloud computing’s lasting impact on open, scalable biomedicine.
References
[1] B. Warth, N. Levin, D. Rinehart, J. Teijaro, H. P. Benton, and G. Siuzdak, “Metabolizing data in the cloud,” Trends in Biotechnology, vol. 35, no. 6, pp. 481–483, Jan. 2017, doi: 10.1016/j.tibtech.2016.12.010.